Saturday, December 26, 2020 9:11:55 PM
It was the reason why I took a stake in AMBS is 2012, however MANF is an untapped protein.
While it achieved ODD, it was targeted for 1st in-man clinical studies in 2016 under Catalent Pharma who was hired to perform cGMP for clinical-grade production of MANF, but no progress was ever made.
Its been around for decades, but has yet to make it out of preclinicals:
https://www.researchgate.net/project/Discovery-of-MANF
It sits in pre-clinicals 'proof of concept' for RP, RAO, AMD, DB, PK and MYO-CDI.
If it truly holds the possibility of being a genuine game changer, then why hasn't Gerald advanced it forward given unlimited time and opportunities to do so?
FEATURED Element79 Gold Corp Reports Exceptionally High-Grade Results from Lucero • May 14, 2024 7:00 AM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM